Sinacort 0.1% (Ointment)
10 gm tube: ৳ 21.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Betamethasone valerate |
| Company | Ibn sina pharmaceuticals ltd |
| Also available as |
Indications
- Treatment of Eczema in children and adults
- Treatment of psoriasis in children and adults
- Treatment of Prurigo nodularis
- Treatment of Neurodermatoses including lichen simplex and lichen planus
- Treatment of Seborrhoic dermatitis
- Treatment of Contact sensitivity reaction
- Adjunct to systemic steroid therapy in generalized erythroderma
Pharmacology
- Synthetic adrenocorticosteroid
- Glucocorticoid in nature
- Anti-inflammatory
- Antipruritic
- Vasoconstrictive activity
- Absorbed from the skin
- Increased percutaneous absorption from the skin due to inflammation
Dosage & Administration
- Apply sparingly to the affected area
- Two or three times daily until improvement occurs
- Twice daily or less after improvement
- Maximum therapy duration of three weeks
Interaction
No significant drug interactions reported
Contraindications
- Hypersensitivity to any ingredients
- Rosaceae & acne vulgaris
- Perioral dermatitis, perianal & genital pruritis
- Viral infections of the skin (e.g. herpes simplex & chicken pox)
- Primary infected skin lesions caused by fungi or bacteria
- Dermatoses in children under one year of age
Side Effects
- Dryness
- Itching
- Burning
- Skin thinning
- Local irritation
- Features of hypercorticolism
- Telagiectasia
- Striae
- Skin atrophy
- Hypertrichosis
- Change in pigmentation
- Secondary infection
- Perioral dermatitis
- Allergic contact dermatitis
- Maceration of the skin
- Acneform eruption
- Exacerbation of symptoms
Pregnancy & Lactation
Should not be used extensively in pregnancy
Precautions & Warnings
- Signs of hypersensitivity - stop application
- Avoid long-term continuous topical therapy, especially in children
- Adrenal suppression may occur without occlusion
- Systemic absorption may produce symptoms of hypercortisolism
- Atrophic changes after prolonged treatment
- Avoid application to eyelids to prevent glaucoma
- Withdrawal of topical corticosteroid therapy if spread of infection occurs
Therapeutic Class
Corticosteroid
Storage Conditions
Keep below 30°C, away from light and moisture